Tecentriq (atezolizumab)

pCPA File Number: 21167
Negotiation Status:
Under consideration for negotiation
Indication(s):
Small Cell Lung Cancer
Sponsor/Manufacturer:
Hoffmann-La Roche
CADTH Project Number:
10156
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable